Literature DB >> 10852618

A polymerase chain reaction-based protocol for the detection of transmission of pig endogenous retroviruses in pig to human xenotransplantation.

J H Blusch1, C Roos, H Nitschko.   

Abstract

BACKGROUND: Xenotransplantation of pig organs and tissues to humans bears the risk of infection of immunosuppressed recipients by porcine endogenous retrovirus (PERV) released from the transplanted tissue. However, when diagnosing potential PERV transmission, it is essential to exclude microchimerism, i.e., persisting pig cells in analyzed bioptic material of xenotransplanted patients, which give rise to false positive PERV signals. Polymerase chain reaction (PCR) is so far the only suitable method to diagnose a cross-species transfer of PERV, but the exclusion of microchimerism might be a serious problem because most of the presently employed primer pairs detect PERV sequences with higher sensitivity than primers used for the detection of contaminating pig sequences.
METHODS: We designed and evaluated a novel and improved primer set for detection of pig sequences as well as complementing positive control primers on the basis of mitochondrial cytochrome B, an approved marker for phylogenetic studies. We further established primer pairs derived from the long terminal repeat/leader region of PERV isolated from a Duroc German Landrace cross-bred pig and tested their sensitivity in comparison with known PERV- and pig-specific PCR markers.
RESULTS: In standard PCR assays, the new cytochrome B-derived primers are at least 10 times more sensitive than the presently used PERV retroviral polymerase gene and mammalian beta-actin primers. When tested in a tissue culture infection model, PERV transmission to human 293 cells can be unambiguously demonstrated, even in the presence of up to 10% pig cells. One of the primer combinations derived from the PERV DuxDL3791 long terminal repeat/leader region amplifies with even lower sensitivity than primers detecting porcine beta-globin, thus permitting the exclusion of microchimerism also via chromosomal loci.
CONCLUSIONS: The availability of the new PCR markers allows the proposal of a rigorous setup for the routine detection of PERV transmission after xenotransplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852618     DOI: 10.1097/00007890-200005270-00036

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Infection of nonhuman primate cells by pig endogenous retrovirus.

Authors:  J H Blusch; C Patience; Y Takeuchi; C Templin; C Roos; K Von Der Helm; G Steinhoff; U Martin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

3.  Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study.

Authors:  Bing Han; Xiao-Lei Shi; Yue Zhang; Xue-Hui Chu; Jin-Yang Gu; Jiang-Qiang Xiao; Hao-Zhen Ren; Jia-Jun Tan; Zhong-Ze Gu; Yi-Tao Ding
Journal:  Eur J Med Res       Date:  2012-05-25       Impact factor: 2.175

Review 4.  Virus Safety of Xenotransplantation.

Authors:  Joachim Denner
Journal:  Viruses       Date:  2022-08-30       Impact factor: 5.818

5.  Comparison of the age-related porcine endogenous retrovirus (PERV)expression using duplex RT-PCR.

Authors:  Hyoung Joon Moon; Hye Kwon Kim; Seong Jun Park; Chul Seung Lee; Dae Sub Song; Bo Kyu Kang; Bong Kyun Park
Journal:  J Vet Sci       Date:  2009-12       Impact factor: 1.672

6.  Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation.

Authors:  Randi Lassiter; Todd D Merchen; Xuexiu Fang; Youli Wang
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

Review 7.  Porcine endogenous retroviruses in xenotransplantation--molecular aspects.

Authors:  Magdalena C Kimsa; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Joanna Gola; Peter Nicholson; Krzysztof Lopata; Urszula Mazurek
Journal:  Viruses       Date:  2014-05-13       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.